Weave Ranks No. 1 in G2's Summer 2026 Patient Relationship Management Grid Report
Weave Ranks No. 1 in G2's Summer 2026 Patient Relationship Management Grid Report
Driven by verified reviews, Weave wins on secure communications and patient experience management
Weave (NYSE: WEAV), a leading AI-powered patient engagement and payments platform purpose-built for healthcare practices, has been named the No. 1 Leader in G2's Summer 2026 Grid® Report for Patient Relationship Management (PRM) software, earning the highest satisfaction score and largest market presence of any product in the category.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708242441/en/

Weave demonstrates leadership in the G2 Grid for Patient Relationship Management (PRM), Summer 2026
"Being named the No. 1 PRM platform in G2's Summer report reflects the trust our customers place in us every day," said Brett White, Chief Executive Officer of Weave. "Our vision is to deliver a better healthcare experience at every practice, for every patient, with every interaction. These results — driven entirely by verified customer feedback — affirm that we're realizing that vision and making a real difference for the practices we serve."
Where Weave Wins According to Customers
Weave's top ranking is driven by a combination of satisfaction ratings and standout feature scores, including:
- Secure Communications (96%)
- Patient Experience Management (95%)
- Ease of Administration (94%)
- Ease of Use (94%)
- Team Management (92%)
Weave earned its Leader designation through G2's dual-axis methodology, which scores products on customer satisfaction (derived from verified user reviews) and market presence (based on market share, seller size, and social impact). The Summer 2026 Report reflects reviews collected through April 28, 2026.
“Only about 10% of all vendors on G2 typically earn a spot in our quarterly Market Reports—making Weave’s recognition a true accomplishment,” said Eric Gilpin, President, GTM at G2. “This honor reflects the strong satisfaction of Weave’s customers and the trust buyers place in G2’s data-driven methodology.”
Beyond its No. 1 ranking in the overall PRM Grid Report, Weave holds Leader status across multiple adjacent G2 categories, including Patient Intake, Patient Engagement, Patient Scheduling, HIPAA Compliant Messaging, Optometry, Veterinary Practice Management, and AI Patient Engagement & Operations.
To learn more about Weave, visit getweave.com or read the full G2 report here.
About Weave
Weave is a leading vertical SaaS company delivering an AI-powered patient engagement and payments platform purpose-built for modern healthcare practices. More than software, Weave is an always-on teammate — handling patient interactions across voice and text and operating at the center of the patient journey. Through agentic AI workflows and authorized integrations with practice management systems, Weave ensures critical tasks like scheduling, insurance verification, and payments happen seamlessly, with nothing falling through the cracks. By embedding AI directly into daily operations, Weave reduces administrative workload, frees staff to focus on human-centered care, and delivers real-time insights that help practices run smarter and grow with confidence. Serving more than 40,000 customer locations, Weave was named a 2026 Best Software Awards winner for healthcare software by G2. To learn more, visit getweave.com/newsroom.
Chelsea Kilpack
Internal Communications & PR Manager, Weave
pr@getweave.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260708242441/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
2 Undervalued Stocks to Buy Before They Rebound